Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
AnGes MG has already been clinically developing the use of HGF gene for ischemic heart disease (IHD) in the U.S. This patent strongly supports the further application of HGF gene for other new heart diseases. In addition to the U.S., AnGes MG has filed patent applications for the present invention in Asian countries including Japan, and European countries. AnGes MG has globally filed patent applications with targets such as Parkinson’s disease, dermatosis and hearing impairment in addition to the abovementioned current clinical development and is making efforts to establish related intellectual property rights. ( www.anges-mg.com )
AnGes MG , Inc.
12707 High Bluff Drive Suite 200
San Diego, California 92130
USA
Tel: (858) 350-4242
Fax: (858) 794-1450